Axsome Therapeutics Inc AXSM:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/08/23 EST
64.96quote price arrow down-0.99 (-1.50%)
Volume
649,863
52 week range
20.63 - 82.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close64.96
  • 52 Week High82.00
  • 52 Week High Date12/13/22
  • 52 Week Low20.63
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap2.821B
  • Shares Out43.43M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.90
  • YTD % Change-15.78

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close64.96
  • 52 Week High82.00
  • 52 Week High Date12/13/22
  • 52 Week Low20.63
  • 52 Week Low Date06/16/22
  • Market Cap2.821B
  • Shares Out43.43M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.90
  • YTD % Change-15.78

RATIOS/PROFITABILITY

  • EPS (TTM)-4.07
  • P/E (TTM)-15.97
  • Fwd P/E (NTM)-15.74
  • EBITDA (TTM)-149.749M
  • ROE (TTM)-159.81%
  • Revenue (TTM)25.67M
  • Gross Margin (TTM)88.67%
  • Net Margin (TTM)-622.90%
  • Debt To Equity (MRQ)59.68%

EVENTS

  • Earnings Date02/27/2023
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Axsome Therapeutics Inc

 

Profile

MORE
Axsome Therapeutics, Inc. is a biopharmaceutical company. The Company is developing novel therapies for central nervous system (CNS) disorders for which there are limited treatment options. It is developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. The Company's CNS portfolio includes four product candidates, such as AXS-05, AXS-07, AXS-12, and AXS-14. AXS-05 is being developed for the treatment of major...
Herriot Tabuteau M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Mark Jacobson
Chief Operating Officer
Nick Pizzie CPA
Chief Financial Officer
Hunter Murdock Esq.
Executive Vice President - Legal and Compliance
Lori Englebert
Executive Vice President - Commercial and Business Development
Address
22 Cortlandt Street, 16Th Floor
New York, NY
10007
United States

Top Peers

SYMBOLLASTCHG%CHG
ISEE
IVERIC bio Inc
21.05-1.72-7.55%
PRTA
Prothena Corporation PLC
55.32-1.88-3.28%
PCVX
Vaxcyte Inc
45.17-0.31-0.68%
RLAY
Relay Therapeutics Inc
20.37-0.95-4.46%
NTLA
Intellia Therapeutics Inc
43.11-1.71-3.82%